Intrinsiqq
Grace Therapeutics Inc. logo

Grace Therapeutics Inc. Dividend Analysis

GRCE

Compare
Dividend0
No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does Grace Therapeutics (GRCE) pay a dividend?

Grace Therapeutics (GRCE) has never paid a dividend. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Grace Therapeutics (GRCE) pay a dividend?+

No. Grace Therapeutics (GRCE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does Grace Therapeutics return cash to shareholders?+

It largely does not. Grace Therapeutics pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Grace Therapeutics afford to pay a dividend?+

Not currently. Grace Therapeutics's free cash flow is negative at -$9 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Grace Therapeutics.

SourceDividend analysis computed from the 10-Q filed 11 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 12 Nov 2026. How this is calculated.

Fiscal year ends Mar. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Pharmaceutical Preparations · Pick stocks to compare with GRCE

CompareIntrinsic value
RCUSArcus Biosciences Inc.
$15.62-1.01%10
ASRTAssertio Holdings Inc.
$9.06+0.28%10
SEPNSepterna, Inc.
$38.61-1.51%25
TBPHTheravance Biopharma Inc.
No recent price82
FHTXFoghorn Therapeutics Inc.
$1.72-3.37%46
AMLXAmylyx Pharmaceuticals, Inc.
$26.02-0.69%10
CYTKCytokinetics, Incorporated
$50.78-1.32%18
LFCRLifecore Biomedical, Inc.
$6.39+0.31%21

Spot a number that looks wrong? Check it in GRCE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GRCE

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.